DRUGS MADE IN AMERICA ACQ II CORP
DMII
10.23
-0.02
-0.20%
DRUGS MADE IN AMERICA ACQ II CORP
US · DMII
#3572 by market cap
10.23
-0.02
-0.20%
Periodic snapshot; not a real-time feed.
· 2026-11-20 16:04
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 76.16% -0.77pp
- Institutions
- 74 -1
- As of
- 2026/Q3 vs. prior period
Holder types
Hedge Fund51.67%
Mutual Fund16.04%
Individual/Insider10.57%
Private Company5.62%
Government Pension Fund1.57%
VC/PE Fund0.82%
Public Company0.45%
Other13.27%
Top holders as of 2026-04-15
Drugs Made In America Acquisition II LLC
4.64% · 2.96M sh
Karpus Management Inc.
4.38% · 2.79M sh
Magnetar Capital Partners, LP
4.24% · 2.70M sh
MM Asset Management Inc
4.24% · 2.70M sh
Glazer Capital, LLC
3.68% · 2.34M sh
Highbridge Capital Management, LLC
3.52% · 2.24M sh
Charles Conaway
3.14% · 2.00M sh
Millennium Management LLC
3.13% · 1.99M sh
Hudson Bay Capital Management LP
3.09% · 1.97M sh
Wolverine Asset Management, LLC
2.89% · 1.84M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
10 filings tracked · 6 buys · 2 sells
| Name | Role | Stake |
|---|---|---|
| Glenn Worman | Former Chief Financial Officer | 0.16% |
| Sridhar Prasad | Independent Director | 0.16% |
| Catherine Do | Independent Director | 0.16% |
| Myron Shulgan | Independent Director | 0.16% |
| Drugs Made In America Acquisition II LLC | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2025-09-25 | Glenn Worman | Former Chief Financial Officer | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Sridhar Prasad | Independent Director | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Catherine Do | Independent Director | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Myron Shulgan | Independent Director | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Other Disposition | -400,000 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Private Acquisition | +700,000 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Private Disposition | -7,966,667 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Open Market Derivative Acquisiti | +700,000 | -- |
| 2025-09-23 | Drugs Made In America Acquisition II LLC | -- | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 16:04:04 · For reference only, not investment advice and not tailored to your situation.
DRUGS MADE IN AMERICA ACQ II CORP discussion 0 comments